X4 Pharmaceuticals Revenue
Biotechnology Research • 
Boston, Massachusetts, United States • 51-100 Employees
X4 Pharmaceuticals revenue & valuation
| Annual revenue | $33,100,000 |
| Revenue per employee | $334,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $105,700,000 |
| Total funding | $200,000,000 |
Key Contacts at X4 Pharmaceuticals
Jacob Ehrlich
Senior Director, Procurement And Business Operations
Barbara Grell
Managing Director, Vienna Research Site
Nour Ziyadeh
Senior Director Gcp Quality
Shelby Abel
Sr. Director Of Data Management
Mojgan Meg Anvari
Associate Director, Quality Operations
Katrina Adell
Medical Director, Clinical Development
Christopher Welch
Director, Gmp Manufacturing
Kannan Arunachalam
Director, Drug Substance
Christine Slater
Director, Strategic Project Management - Medical Affairs
Monica Moulton
Director, It Project Management Office
Company overview
| Headquarters | 61 N Beacon St, Boston, Massachusetts 02134, US |
| Phone number | +18575298300 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Rare Disease And Primary Immunodeficiencies |
| Founded | 2014 |
| Employees | 51-100 |
| Socials |
X4 Pharmaceuticals Email Formats
X4 Pharmaceuticals uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@x4pharma.com), used 80.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@x4pharma.com | 80.6% |
{first initial}.{last name} | j.doe@x4pharma.com | 17.7% |
{first initial}.{last name}{last name} | j.doedoe@x4pharma.com | 1.6% |
About X4 Pharmaceuticals
We are a fully integrated, commercial-stage biopharmaceutical company driving progress for people living with rare immune disorders. We listen to people whose challenges have been long overlooked, understand their needs, and develop solutions to their most urgent and critical health concerns. Our FDA-approved medication XOLREMDI® (mavorixafor) is commercially available in the U.S. in its first indication. We are evaluating mavorixafor in additional potential indications, and have an ongoing global, pivotal Phase 3 clinical trial for its use in chronic neutropenia. Our corporate headquarters is in Boston, Massachusetts.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
X4 Pharmaceuticals has 44 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore X4 Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
X4 Pharmaceuticals Tech Stack
Discover the technologies and tools that power X4 Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Webmail
Programming languages
Blogs
Analytics
WordPress plugins
SEO
PaaS
Canada
United Kingdom
SpainFrequently asked questions
4.8
40,000 users
